New hope for patients who have run out of options

NCT ID NCT03838926

Recruiting now Disease control Sponsor: Vanda Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing the safety and side effects of an experimental drug called trichostatin A in adults with blood cancers that have returned or stopped responding to standard treatments. The main goal is to find the highest dose patients can tolerate without severe side effects. Participants have exhausted all other available therapies for their condition.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Vanda Investigational Site
WITHDRAWN

Washington D.C., District of Columbia, 20007, United States
Vanda Investigational Site
COMPLETED

Lafayette, Indiana, 47905, United States
Vanda Investigational Site
WITHDRAWN

Hackensack, New Jersey, 07601, United States
Vanda Investigational Site
COMPLETED

Seattle, Washington, 98109, United States
Vanda Investigational Site
RECRUITING

Biała Podlaska, Poland

Contact Phone: •••-•••-••••
Vanda Investigational Site
RECRUITING

Katowice, Poland

Contact Phone: •••-•••-••••
Vanda Investigational Site
COMPLETED

Krakow, Poland
Vanda Investigational Site
RECRUITING

Opole, Poland

Contact Phone: •••-•••-••••
Vanda Investigational Site
COMPLETED

Skorzewo, Poland
Vanda Investigational Site
RECRUITING

Warsaw, Poland

Contact Phone: •••-•••-••••
Vanda Investigational Site
COMPLETED

Wroclaw, Poland

Conditions

Explore the condition pages connected to this study.

RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES